Nephro Care India Ltd vs Park Medi World Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Nov 01, 2026

Key Highlights

The Latest Trading Price of Nephro Care India Ltd is ₹ 81.3 as of 30 Oct 15:30 . The P/E Ratio of Nephro Care India Ltd changed from 25.4 on March 2026 to 0 on March 2025 . This represents a CAGR of -100.00% over 6 yearsThe P/E Ratio of Park Medi World Ltd changed from 31.7 on March 2026 to 0 on March 2025 . This represents a CAGR of -100.00% over 6 years The Market Cap of Nephro Care India Ltd changed from ₹ 85.32 crore on March 2026 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of Park Medi World Ltd changed from ₹ 8191 crore on March 2026 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 6 years The revenue of Nephro Care India Ltd for the Jun '26 is ₹ 29.41 crore as compare to the Mar '26 revenue of ₹ 27.58 crore. This represent the growth of 6.64% The revenue of Park Medi World Ltd for the Jun '26 is ₹ 483.36 crore as compare to the Mar '26 revenue of ₹ 467.92 crore. This represent the growth of 3.3% The ebitda of Nephro Care India Ltd for the Jun '26 is ₹ 3.84 crore as compare to the Mar '26 ebitda of ₹ 2.85 crore. This represent the growth of 34.74% The ebitda of Park Medi World Ltd for the Jun '26 is ₹ 133.73 crore as compare to the Mar '26 ebitda of ₹ 134.87 crore. This represent the decline of -0.85% The net profit of Nephro Care India Ltd changed from ₹ -0.65 crore to ₹ 1.61 crore over 6 quarters. This represents a CAGR of NaN% The net profit of Park Medi World Ltd changed from ₹ 45.65 crore to ₹ 88.59 crore over 7 quarters. This represents a CAGR of 46.06% The Dividend Payout of Nephro Care India Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Park Medi World Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Nephro Care India Ltd

Nephro Care India Limited was originally incorporated on July 08, 2014 as a Private Limited Company as 'Nephro Care India Private Limited' with the Registrar of Companies, West Bengal.
Subsequently, Company converted into a Public Limited Company and the name of Company was changed to Nephro Care India Limited' and a fresh Certificate of Incorporation dated March 5, 2024, was issued by the Registrar of Companies, Central Processing Centre. Nephro Care was founded in the year 2014 by Dr. Pratim Sengupta in Kolkata with an object of providing comprehensive medical services for renal patients.
The Company is a one stop treatment centre based in Kolkata that offer clinical and lifestyle solutions and services and renal insufficiency treatment to patients.
The treatment framework covers the entire range of lifestyle, physiological and spiritual aspects of wellness.

About Park Medi World Ltd

Park Medi World Quarterly Result Overview Park Medi World quarterly results present a clear summary of financial performance across different reporting periods.
Investors can review revenue, profit, and overall business trends without studying detailed financial statements. Park Medi World quarterly results date helps track when each financial update is released during the year.
The overview shows how the company performs under changing business conditions and the market environment. Key Metrics of Park Medi World Quarterly Result Here are the main metrics typically covered: 1.
Revenue Revenue shows the total income generated from business activities during the reporting period.
Performance changes in quarterly results, such as Park Medi World Q3 results, may reflect seasonal demand and business cycles. 2.

FAQs for the comparison of Nephro Care India Ltd and Park Medi World Ltd

Which company has a larger market capitalization, Nephro Care India Ltd or Park Medi World Ltd?

Market cap of Nephro Care India Ltd is 134 Cr while Market cap of Park Medi World Ltd is 9,513 Cr

What are the key factors driving the stock performance of Nephro Care India Ltd and Park Medi World Ltd?

The stock performance of Nephro Care India Ltd and Park Medi World Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Nephro Care India Ltd and Park Medi World Ltd?

As of November 1, 2026, the Nephro Care India Ltd stock price is INR ₹81.3. On the other hand, Park Medi World Ltd stock price is INR ₹220.25.

How do dividend payouts of Nephro Care India Ltd and Park Medi World Ltd compare?

To compare the dividend payouts of Nephro Care India Ltd and Park Medi World Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.